Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorn L J C Assmann

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 4, 2024
[Normocytic anaemia due to multiple causes]Jorn L J C Assmann, Floor Weerkamp
Haematologica|February 2, 2018
Large granular lymphocyte cells and immune dysregulation diseases - the chicken or the egg?Anton W Langerak, Jorn L J C Assmann
Ejhaem|January 27, 2025
Noninvasive prenatal testing in CLL during pregnancy: A cautionary taleJorn L J C Assmann, Diane Van Opstal, Karin E M Diderich, et al.
Hemasphere|July 20, 2023
Context-dependent T-cell Receptor Gene Repertoire Profiles in Proliferations of T Large Granular LymphocytesJorn L J C Assmann, Elisavet Vlachonikola, Pieter M Kolijn, et al.
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Type of D-dimer assay determines the diagnostic yield of computed tomography in patients suspected for pulmonary embolismJorn L J C Assmann, Adriaan J van Gammeren, Reinier A Sprenger, et al.
Journal of Leukocyte Biology|April 13, 2021
TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patientsJorn L J C Assmann, P Martijn Kolijn, Benjamin Schrijver, et al.
Leukemia|December 7, 2021
miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemiaJorn L J C Assmann, Leticia G Leon, Christiaan J Stavast, et al.
European Cytokine Network|March 2, 2021
Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcomeBenjamin Schrijver, Jorn L J C Assmann, Adriaan J van Gammeren, et al.
Blood|September 9, 2022
Detecting measurable residual disease beyond 10-4 by an IGHV leader-based NGS approach improves prognostic stratification in CLLPaul J Hengeveld, Michèle Y van der Klift, P Martijn Kolijn, et al.
Hemasphere|September 21, 2023
High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLLPaul J Hengeveld, P Martijn Kolijn, Jeroen A A Demmers, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|January 4, 2024
[Normocytic anaemia due to multiple causes]Jorn L J C Assmann, Floor Weerkamp
Haematologica|February 2, 2018
Large granular lymphocyte cells and immune dysregulation diseases - the chicken or the egg?Anton W Langerak, Jorn L J C Assmann
Ejhaem|January 27, 2025
Noninvasive prenatal testing in CLL during pregnancy: A cautionary taleJorn L J C Assmann, Diane Van Opstal, Karin E M Diderich, et al.
Hemasphere|July 20, 2023
Context-dependent T-cell Receptor Gene Repertoire Profiles in Proliferations of T Large Granular LymphocytesJorn L J C Assmann, Elisavet Vlachonikola, Pieter M Kolijn, et al.
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Type of D-dimer assay determines the diagnostic yield of computed tomography in patients suspected for pulmonary embolismJorn L J C Assmann, Adriaan J van Gammeren, Reinier A Sprenger, et al.
Journal of Leukocyte Biology|April 13, 2021
TRB sequences targeting ORF1a/b are associated with disease severity in hospitalized COVID-19 patientsJorn L J C Assmann, P Martijn Kolijn, Benjamin Schrijver, et al.
Leukemia|December 7, 2021
miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemiaJorn L J C Assmann, Leticia G Leon, Christiaan J Stavast, et al.
European Cytokine Network|March 2, 2021
Extensive longitudinal immune profiling reveals sustained innate immune activation in COVID-19 patients with unfavorable outcomeBenjamin Schrijver, Jorn L J C Assmann, Adriaan J van Gammeren, et al.
Blood|September 9, 2022
Detecting measurable residual disease beyond 10-4 by an IGHV leader-based NGS approach improves prognostic stratification in CLLPaul J Hengeveld, Michèle Y van der Klift, P Martijn Kolijn, et al.
Hemasphere|September 21, 2023
High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLLPaul J Hengeveld, P Martijn Kolijn, Jeroen A A Demmers, et al.
Pageof 1